Ffi Fund Ltd - Sep 9, 2021 Form 3 Insider Report for Clarus Therapeutics Holdings, Inc. (CRXT)

Role: 10%+ Owner
Signature: /s/ FFI Fund Ltd., By Gabriel Sunshine, Authorized Representative
Stock symbol: CRXT
Transactions as of: Sep 9, 2021
Transactions value $: $0
Form type: 3
Date filed: 9/17/2021, 04:18 PM
Next filing: Sep 21, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	CRXT	Common Stock						2.23M	Sep 9, 2021	See footnotes	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	2,229,855 of the total reported shares of common stock, $0.0001 par value per share ("Common Stock"), of the Issuer are owned directly as follows: (i) 1,627,795 shares of Common Stock are owned directly by FFI Fund Ltd. ("FFI"), (ii) 312,179 shares of Common Stock are owned directly by FYI Ltd. ("FYI"), and (iii) 289,881 shares of Common Stock are owned directly by Olifant Fund, Ltd. (together with FFI and FYI, the "Bracebridge Funds"). Bracebridge Capital, LLC (the "Investment Manager") is the investment manager of each of the Bracebridge Funds, and has the authority to vote and dispose of all the shares of Common Stock reflected herein.
F2	Each of the Bracebridge Funds and the Investment Manager disclaims beneficial ownership of the shares of Common Stock except to the extent of any pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the shares of Common Stock reported herein for purposes of Section 16 of the Securities Exchange Act of 1934 or for any other purpose.

Content

2,229,855 of the total reported shares of common stock, $0.0001 par value per share ("Common Stock"), of the Issuer are owned directly as follows: (i) 1,627,795 shares of Common Stock are owned directly by FFI Fund Ltd. ("FFI"), (ii) 312,179 shares of Common Stock are owned directly by FYI Ltd. ("FYI"), and (iii) 289,881 shares of Common Stock are owned directly by Olifant Fund, Ltd. (together with FFI and FYI, the "Bracebridge Funds"). Bracebridge Capital, LLC (the "Investment Manager") is the investment manager of each of the Bracebridge Funds, and has the authority to vote and dispose of all the shares of Common Stock reflected herein.

Each of the Bracebridge Funds and the Investment Manager disclaims beneficial ownership of the shares of Common Stock except to the extent of any pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the shares of Common Stock reported herein for purposes of Section 16 of the Securities Exchange Act of 1934 or for any other purpose.